Analytical Data
-
基因名
RAB35
- Application
-
别名
(GTP-binding protein RAY)(Ras-related protein Rab-1C)
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q15286
-
表达区间
1-201aa
-
分子量
54.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RAB35 is a member of the RAS superfamily of small GTPases, playing a crucial role in various cellular processes, including vesicle trafficking, endocytosis, and membrane dynamics. Recent studies have highlighted its importance in regulating membrane transport events, particularly in relation to the recycling of endosomal vesicles. Dysregulation of RAB35 has been implicated in various diseases, including cancer and neurodegenerative disorders, making it a significant target for therapeutic interventions. The ability to produce recombinant RAB35 protein is essential for understanding its structural and functional properties, as well as its interactions with other cellular components. By studying RAB35 in a recombinant system, researchers aim to elucidate its mechanistic roles in intracellular pathways and its potential as a biomarker or therapeutic target. Furthermore, understanding the signaling pathways mediated by RAB35 may provide insights into the broader network of cellular regulation and how alterations in this protein contribute to disease pathology. Consequently, the development of recombinant RAB35 not only enhances our basic knowledge of cellular mechanisms but also opens up new avenues for the development of biotechnological and pharmacological applications.
